Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.
- 28 February 1995
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 92 (5) , 1401-1405
- https://doi.org/10.1073/pnas.92.5.1401
Abstract
Recombinant adenoviruses containing the canine factor IX (FIX) cDNA were directly introduced in the hind leg muscle of mice. We show that (i) in nude mice, high expression (1-5 micrograms/ml in plasma) of FIX protein can be detected for > 300 days; (ii) in contrast, expression of FIX protein was transient (7-10 days) in normal mice; (iii) CD8+ lymphocytes could be detected within 3 days in the infected muscle tissue; (iv) use of beta 2-microglobulin and immunoglobulin M heavy chain "knockout" mice showed that lack of sustained expression of FIX protein is due to cell-mediated and humoral immune responses; (v) normal mice, once infected with recombinant adenovirus, could not be reinfected efficiently for at least 30 days due to neutralizing viral antibodies; and, finally, (vi) using immunosuppressive drugs, some normal mice can be tolerized to produce and secrete FIX protein for > 5 months. We conclude that currently available adenoviral vectors have serious limitations for use for long-term gene therapy.Keywords
This publication has 23 references indexed in Scilit:
- Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.Proceedings of the National Academy of Sciences, 1994
- Adenovirus as an expression vector in muscle cells in vivo.Proceedings of the National Academy of Sciences, 1992
- Cytotoxic suppression of acquired factor VIII:C inhibitorsThe American Journal of Medicine, 1991
- Adenovirus-Mediated Transfer of a Recombinant α1-Antitrypsin Gene to the Lung Epithelium in VivoScience, 1991
- A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain geneNature, 1991
- Evaluation of the Transfer and Expression in Mice of an Enzyme-Encoding Gene Using a Human Adenovirus VectorHuman Gene Therapy, 1990
- Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs.Proceedings of the National Academy of Sciences, 1990
- Inactivating the beta 2-microglobulin locus in mouse embryonic stem cells by homologous recombination.Proceedings of the National Academy of Sciences, 1989
- An alternative approach to somatic cell gene therapy.Proceedings of the National Academy of Sciences, 1988
- Genetic Analysis of AdenovirusesPublished by Springer Nature ,1984